We are live on ! Find out more
GSK icon

GSK
GSK

792 hedge funds and large institutions have $12.4B invested in GSK in 2021 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 297 increasing their positions, 231 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $327M | Put options by funds: $163M

29% more repeat investments, than reductions

Existing positions increased: 297 | Existing positions reduced: 231

10% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 68

0.07% more ownership

Funds ownership: 5.08% → 5.14% (+0.07%)

1% less funds holding

Funds holding: 798 → 792 (-6)

3% less capital invested

Capital invested by funds: $12.7B → $12.4B (-$357M)

7% less funds holding in top 10

Funds holding in top 10: 14 → 13 (-1)

Holders
792
Holders Change
-6
Holders Change %
-0.75%
% of All Funds
13.87%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.23%
New
75
Increased
297
Reduced
231
Closed
68
Calls
$327M
Puts
$163M
Net Calls
+$164M
Net Calls Change
+$97M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$136M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$131M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$77.5M
4
BCIM
Black Creek Investment Management
Ontario, Canada
+$49.9M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$20.6M

Top Sellers

Rank Fund Capital Flow
1
Nomura Holdings
Nomura Holdings
Japan
-$155M
2
CA
Capitolis Advisors
New York
-$60.7M
3
Barclays
Barclays
United Kingdom
-$45.3M
4
JEST
JTC Employer Solutions Trustee
Jersey
-$43.9M
5
BCAM
Boston Common Asset Management
Massachusetts
-$29.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
CPFP
851
Clear Perspectives Financial Planning
Ohio
– -$9K -182 Closed
PWP
852
Personal Wealth Partners
Minnesota
– -$9K -182 Closed
HF
853
Halpern Financial
Virginia
– -$8.59K -171 Closed
TAM
854
Tucker Asset Management
Colorado
– -$6.69K -134 Closed
M1FG
855
Mach-1 Financial Group
Arkansas
– -$4K -91 Closed
FFA
856
Freedman Financial Associates
Massachusetts
– -$3K -56 Closed
SB
857
Strategic Blueprint
Georgia
– -$2K -41 Closed
M
858
MOTCO
Texas
– -$2K -35 Closed
LSA
859
Lion Street Advisors
Texas
– -$1.59K -32 Closed
CPC
860
Consolidated Planning Corp
Georgia
– +$100 +2 New
TWP
861
TFO Wealth Partners
Ohio
– +$301 +6 New
31 32 33 34
35

GSK Hedge Fund Activity: Q3 2021 in Review

792 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q3 2021, worth a combined $12.4B — down 2.8% from $12.7B a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new GSK positions and 68 closed out — a net gain of 7 holders — while 297 added to existing stakes and 231 trimmed.

The largest buyer was Two Sigma Investments, adding an estimated $136M. The largest seller was Nomura Holdings, cutting an estimated $155M.

  • 792 institutional investors held GSK (GSK) as of Q3 2021, down from 798 in Q2 2021.
  • Funds reported $12.4B of GSK stock for Q3 2021, down 2.8% quarter-over-quarter.
  • 75 funds opened new GSK positions in Q3 2021 and 68 closed out, a net change of +7 holders.
  • The largest GSK buyer in Q3 2021 was Two Sigma Investments, an estimated $136M added.
  • The largest GSK seller in Q3 2021 was Nomura Holdings, an estimated $155M sold.

Based on aggregated 13F filings for Q3 2021.